Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127254461 | 12725446 | 1 | I | 201512 | 20160831 | 20160908 | 20160908 | EXP | US-INCYTE CORPORATION-2016IN005519 | INCYTE | 80.06 | YR | M | Y | 0.00000 | 20160908 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127254461 | 12725446 | 1 | PS | JAKAFI | RUXOLITINIB | 1 | Oral | 5 MG, BID | U | U | 202192 | 5 | MG | TABLET | BID | ||||
| 127254461 | 12725446 | 2 | SS | JAKAFI | RUXOLITINIB | 1 | Oral | 10 MG, BID | U | U | 202192 | 10 | MG | TABLET | BID | ||||
| 127254461 | 12725446 | 3 | SS | VIDAZA | AZACITIDINE | 1 | Unknown | UNK | U | 0 | |||||||||
| 127254461 | 12725446 | 4 | C | AMLODIPINE | AMLODIPINE BESYLATE | 1 | Unknown | UNK | 0 | ||||||||||
| 127254461 | 12725446 | 5 | C | OMEPRAZOLE. | OMEPRAZOLE | 1 | Unknown | UNK | 0 | ||||||||||
| 127254461 | 12725446 | 6 | C | SIMVASTATIN. | SIMVASTATIN | 1 | Unknown | UNK | 0 | ||||||||||
| 127254461 | 12725446 | 7 | C | MONTELUKAST | MONTELUKAST SODIUM | 1 | Unknown | UNK | 0 | ||||||||||
| 127254461 | 12725446 | 8 | C | VALACYCLOVIR | VALACYCLOVIR HYDROCHLORIDE | 1 | Unknown | UNK | 0 | ||||||||||
| 127254461 | 12725446 | 9 | C | TRIAMCINOLONE ACETONIDE. | TRIAMCINOLONE ACETONIDE | 1 | Unknown | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127254461 | 12725446 | 1 | Myelofibrosis |
| 127254461 | 12725446 | 3 | Product used for unknown indication |
| 127254461 | 12725446 | 4 | Product used for unknown indication |
| 127254461 | 12725446 | 5 | Product used for unknown indication |
| 127254461 | 12725446 | 6 | Product used for unknown indication |
| 127254461 | 12725446 | 7 | Product used for unknown indication |
| 127254461 | 12725446 | 8 | Product used for unknown indication |
| 127254461 | 12725446 | 9 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127254461 | 12725446 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127254461 | 12725446 | Hypersensitivity | |
| 127254461 | 12725446 | Pain | |
| 127254461 | 12725446 | Pigmentation disorder | |
| 127254461 | 12725446 | Platelet count decreased | |
| 127254461 | 12725446 | Pruritus | |
| 127254461 | 12725446 | Pyrexia | |
| 127254461 | 12725446 | Rash |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127254461 | 12725446 | 1 | 201508 | 0 |